Oxford BioDynamics's market cap is currently £11.12M. The company's EPS TTM is p-0.064; its P/E ratio is ―; Oxford BioDynamics is scheduled to report earnings on January 28, 2025, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Sep 22	Sep 21	Sep 20	Sep 19
Income Statement
Total Revenue	£ 510.00K	£ 154.00K	£ 341.00K	£ 456.00K	£ 907.00K
Gross Profit	£ 266.00K	£ 116.00K	£ -557.00K	£ -166.00K	£ 439.00K
Operating Income	£ -11.03M	£ -8.60M	£ -7.51M	£ -4.95M	£ -3.72M
EBITDA	£ -9.84M	£ -6.16M	£ -6.43M	£ -4.42M	£ -3.00M
Net Income	£ -10.83M	£ -6.71M	£ -6.68M	£ -4.31M	£ -2.80M
Balance Sheet
Cash & Short-Term Investments	£ 5.25M	£ 999.00K	£ 4.34M	£ 11.51M	£ 15.50M
Total Assets	£ 16.13M	£ 11.34M	£ 15.38M	£ 15.35M	£ 18.79M
Total Debt	£ 6.44M	£ 6.14M	£ 6.59M	£ 541.00K	£ 0.00
Net Debt	£ 1.19M	£ 5.16M	£ 4.41M	£ -5.58M	£ -5.20M
Total Liabilities	£ 10.07M	£ 8.76M	£ 8.69M	£ 1.77M	£ 1.20M
Stockholders' Equity	£ 6.05M	£ 2.59M	£ 6.68M	£ 13.56M	£ 17.57M
Cash Flow
Free Cash Flow	£ -9.01M	£ -6.08M	£ -9.01M	£ -3.86M	£ -2.90M
Operating Cash Flow	£ -8.29M	£ -5.18M	£ -5.92M	£ -3.40M	£ -2.27M
Investing Cash Flow	£ -691.00K	£ 1.25M	£ 2.83M	£ 4.58M	£ -11.19M
Financing Cash Flow	£ 13.42M	£ 2.56M	£ -804.00K	£ -181.00K	£ 236.00K

Currency in GBP

Oxford BioDynamics Earnings and Revenue History

Income Statement >

Oxford BioDynamics Debt to Assets

Balance Sheet >

Oxford BioDynamics Cash Flow

Cash Flow >

Oxford BioDynamics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing